AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced that Eric Easom, Co-Founder, President and CEO, will present at the Jefferies Healthcare Conference. Details of the event are as follows: Jefferies Healthcare Conference, June 7-9, 2023 in New York, NY. Eric Easom, Co-Founder, President and CEO, will provide a corporate overview on Thursday,...